Literature DB >> 11330829

Strain difference (WKY, SPRD) in the hepatic antioxidant status in rat and effect of hypertension (SHR, DOCA). Ex vivo and in vitro data.

D Binda1, L Nicod, C Viollon-Abadie, S Rodriguez, A Berthelot, P Coassolo, L Richert.   

Abstract

We assessed the hepatic antioxidant status of spontaneously (SHR) and desoxicorticosterone acetate (DOCA)-induced hypertensive rats and that of respective normotensive Wistar Kyoto (WKY) and Sprague-Dawley (SPRD) rats. For this we evaluated, ex vivo in liver cytosols, reduced glutathione (GSH) content, glutathione-related enzyme (peroxidase, reductase and transferase) activities as well as the rate of lipid peroxidation in 9-11 week-old rats. The antioxidant status and the cytotoxicity of acetaminophen, a radical- and hydrogen peroxide-mediated hepatotoxic compound, were also assessed in vitro in cultured hepatocytes isolated from hypertensive (SHR, DOCA) and normotensive control (WKY, SPRD) rats. Our results suggest that a difference exists in the hepatic antioxidant status between rat strains, with GSH levels being lower (-15%) and lipid peroxidation rate higher (+30%) in WKY compared to SPRD rats. In hepatocyte cultures from WKY rats, both GSH content and catalase activity were lower (-30 and -70% respectively) compared to hepatocyte cultures from SPRD rats. This was associated with a 35% higher cytotoxicity of acetaminophen in cultured hepatocytes from WKY rats compared to that in hepatocytes from SPRD rats. Hypertension in DOCA rats (mmHg: 221+/-9 vs. 138+/-5 in control SPRD rats) was associated with decreases (about 30%) in both glutathione peroxidase (GSH-Px) and catalase activities, ex vivo in livers and in vitro in hepatocyte cultures. Hypertension in SHR (mmHg: 189+/-7 vs. 130+/-5 in control WKY rats) was also associated with decreases (about 50%) in GSH-Px activity, ex vivo in livers and in vitro in hepatocyte cultures but catalase activity was not modified. The IC50 of acetaminophen was also lower in hepatocytes from hypertensive rats compared to respective controls, which could be related to the weakened antioxidant status in hepatocytes from hypertensive rats. Our data thus suggest that hepatocyte cultures are appropriated tools in which to assess hepatotoxicity and hepatoprotection in hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11330829     DOI: 10.1023/a:1007268825721

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  36 in total

Review 1.  The role of nitric oxide in hepatic metabolism.

Authors:  B Alexander
Journal:  Nutrition       Date:  1998-04       Impact factor: 4.008

2.  Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.

Authors:  V Goll; E Alexandre; C Viollon-Abadie; L Nicod; D Jaeck; L Richert
Journal:  Toxicol Appl Pharmacol       Date:  1999-10-01       Impact factor: 4.219

3.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

4.  Blunted nocturnal fall in blood pressure and oxidative stress in men and women with essential hypertension.

Authors:  S D Pierdomenico; F Costantini; A Bucci; D De Cesare; T Bucciarelli; F Cuccurullo; A Mezzetti
Journal:  Am J Hypertens       Date:  1999-04       Impact factor: 2.689

5.  Antioxidant properties of S-adenosyl-L-methionine: a proposed addition to organ storage fluids.

Authors:  P J Evans; M Whiteman; J M Tredger; B Halliwell
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

6.  Clofibric acid or diethylmaleate supplemented diet decrease blood pressure in DOCA-salt treated male Sprague Dawley rats--relation with liver antioxidant status.

Authors:  L Nicod; S Rodriguez; A Jacqueson; C Viollon-Abadie; A Berthelot; L Richert
Journal:  Mol Cell Biochem       Date:  2000-10       Impact factor: 3.396

7.  Comparison of the induction of hepatic peroxisome proliferation by the herbicide oxadiazon in vivo in rats, mice, and dogs and in vitro in rat and human hepatocytes.

Authors:  L Richert; S Price; C Chesne; K Maita; N Carmichael
Journal:  Toxicol Appl Pharmacol       Date:  1996-11       Impact factor: 4.219

8.  The response of the antioxidant defense system in rat hepatocytes challenged with oxysterols is modified by Covi-ox.

Authors:  H Cantwell; R Devery
Journal:  Cell Biol Toxicol       Date:  1998-12       Impact factor: 6.691

9.  Age-related changes in antioxidant defence mechanisms and peroxidation in isolated hepatocytes from spontaneously hypertensive and normotensive rats.

Authors:  E Véricel; M Narce; L Ulmann; J P Poisson; M Lagarde
Journal:  Mol Cell Biochem       Date:  1994-03-16       Impact factor: 3.396

10.  Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide.

Authors:  C G Schnackenberg; W J Welch; C S Wilcox
Journal:  Hypertension       Date:  1998-07       Impact factor: 10.190

View more
  8 in total

1.  Effect of Aqueous Extract of Adansonia digitata Stem Bark on the Development of Hypertension in L-NAME-Induced Hypertensive Rat Model.

Authors:  Fidèle Ntchapda; Christian Bonabe; Albert Donatien Atsamo; David Romain Kemeta Azambou; Yannick Bekono Fouda; Soudy Imar Djibrine; Paul F Seke Etet; Dimo Théophile
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-18       Impact factor: 2.629

2.  Dietary vitamin C supplementation decreases blood pressure in DOCA-salt hypertensive male Sprague-Dawley rats and this is associated with increased liver oxidative stress.

Authors:  Fatiha Elhaïmeur; Carol Courderot-Masuyer; Laurence Nicod; Catherine Guyon; Lysiane Richert; Alain Berthelot
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

3.  Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats.

Authors:  Milagros Galisteo; Maria Francisca García-Saura; Rosario Jiménez; Inmaculada Concepción Villar; Antonio Zarzuelo; Félix Vargas; Juan Duarte
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

4.  Honey supplementation in spontaneously hypertensive rats elicits antihypertensive effect via amelioration of renal oxidative stress.

Authors:  Omotayo O Erejuwa; Siti A Sulaiman; Mohd S Ab Wahab; Kuttulebbai N S Sirajudeen; Salzihan Salleh; Sunil Gurtu
Journal:  Oxid Med Cell Longev       Date:  2012-01-23       Impact factor: 6.543

5.  Integrated genomic approaches to identification of candidate genes underlying metabolic and cardiovascular phenotypes in the spontaneously hypertensive rat.

Authors:  Catherine Morrissey; Ian C Grieve; Matthias Heinig; Santosh Atanur; Enrico Petretto; Michal Pravenec; Norbert Hubner; Timothy J Aitman
Journal:  Physiol Genomics       Date:  2011-08-16       Impact factor: 3.107

6.  Ellagic Acid Prevents L-NAME-Induced Hypertension via Restoration of eNOS and p47phox Expression in Rats.

Authors:  Thewarid Berkban; Pattanapong Boonprom; Sarawoot Bunbupha; Jariya Umka Welbat; Upa Kukongviriyapan; Veerapol Kukongviriyapan; Poungrat Pakdeechote; Parichat Prachaney
Journal:  Nutrients       Date:  2015-06-30       Impact factor: 5.717

7.  Hepatoprotective Effect of Silymarin (Silybum marianum) on Hepatotoxicity Induced by Acetaminophen in Spontaneously Hypertensive Rats.

Authors:  Abel Felipe Freitag; Gabriel Fernando Esteves Cardia; Bruno Ambrósio da Rocha; Rafael Pazzinatto Aguiar; Francielli Maria de Souza Silva-Comar; Ricardo Alexandre Spironello; Renata Grespan; Silvana Martins Caparroz-Assef; Ciomar Aparecida Bersani-Amado; Roberto Kenji Nakamura Cuman
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

8.  Effect of Clonidine (an antihypertensive drug) treatment on oxidative stress markers in the heart of spontaneously hypertensive rats.

Authors:  Nik Syamimi Nik Yusoff; Zulkarnain Mustapha; Chandran Govindasamy; K N S Sirajudeen
Journal:  Oxid Med Cell Longev       Date:  2013-05-16       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.